Search
for
Sort by
Research 30 of 1000+
- Prevalence of autoimmune and inflammatory diseases and mental health conditions among an alopecia areata cohort from a US administrative claims database
- Comparing the burden of illness in patients with alopecia areata vs atopic dermatitis in the US population from a payer perspective
- Gender identity and transition: relationships with sleep disorders in US youth
- Finasteride and male infertility: a case for prospective collaborative research databases?
- Real-world study of adverse events associated with gepant use in migraine treatment based on the VigiAccess and U.S. Food and Drug Administration’s adverse event reporting system databases
- Incidence Rates of Infections, Malignancies, Thromboembolism, and Cardiovascular Events in an Alopecia Areata Cohort from a US Claims Database
- Psoriasis and psoriatic arthritis patient productivity burden in the United States
- Egr-1 is main key regulator in IL-17F-induced psoriasin expression in human keratinocytes
- Alopecia Areata Treatment Patterns, Healthcare Resource Utilization, and Comorbidities in the US Population Using Insurance Claims
- Is the Safety of Finasteride Correlated With Its Route of Administration: Topical Versus Oral? A Pharmacovigilance Study With Data From the United States Food and Drug Administration Adverse Event Reporting System
- Risk of Safety Events in Vitiligo Patients: A Retrospective Real‐World Data Study in the US
- Are finasteride-related penile curvature/Peyronie’s disease Adverse Event Reports worthy of further clinical investigation? Disproportionality analysis based on both the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) pharmacovigilance databases
- Identifying barriers and disparities in the healthcare of patients with alopecia areata: a mixed-methods analysis using claims data and qualitative interview data
- Prevalence, comorbidities, and treatment patterns of Japanese patients with alopecia areata: A descriptive study using Japan medical data center claims database
- A retrospective analysis of disease epidemiology, comorbidities, treatment patterns, and healthcare resource utilization of alopecia areata in the United Arab Emirates using claims database
- Comparative Analysis of Labeling and Claim Substantiation Requirements for Herbal Hair Products across Different Regulatory Jurisdictions
- Healthcare Utilization and Costs Among US Adolescents With Alopecia Areata
- What can the hair tell us about COVID‐19?
- Assessing the real-world safety of tralokinumab for atopic dermatitis: insights from a comprehensive analysis of FAERS data
- Economic Burden and Healthcare Resource Use of Alopecia Areata in an Insured Population in the USA
- Trends in Prevalence and Incidence of Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Among Adults and Children in a US Employer-Sponsored Insured Population
- STEROIDS AND STEROID-LIKE COMPOUNDS
- Validation of <i>International Classification of Diseases</i> Codes for Dermatologic Conditions
- Current Concepts and Translational Uses of Platelet Rich Plasma Biotechnology
- Adverse events of the thyroid peroxidase inhibitor methimazole in the treatment of hyperthyroidism: a comprehensive analysis from the first quarter of 2004 to the first quarter of 2025
- Patient characteristics associated with all-cause healthcare costs of alopecia areata in the United States
- US clinics marketing unproven and unlicensed adipose-derived autologous stem cell interventions
- Real-World Treatment Patterns among Patients with Alopecia Areata in the USA: A Retrospective Claims Analysis
- Economic analysis of finasteride: A model-based approach using data from the Proscar long-term efficacy and safety study
- Evaluation of dermatologic adverse events associated with aromatase inhibitors: insights from the FAERS database